Analysis of Intellectual Property Protection Strategy of Transnational Biotechnology Corporation——Taking MON531 of Cotton Event for Example

doi:10.13523/j.cb.20140616

China Biotechnology

2014, Vol. 34

Issue (06): 110-116 DOI: 10.13523/j.cb.20140616

Analysis of Intellectual Property Protection Strategy of Transnational Biotechnology Corporation——Taking MON531 of Cotton Event for Example

SONG Min, LIU Na, REN Xin-xin, LU Yao

Institute of Agricultural Resources and Regional Planning, CAAS/China Center for Intellectual Property, CAAS, Beijing 100081, China

Download:

HTML

PDF(677KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract

In the past years, the planting area of the transgenic cotton has a rapid growth in many countries. For further study on technology systems and intellectual property protection of transgenic insect-resistant cotton, the intellectual property strategy of transnational biotechnology Corporation has been studied——taking cotton event MON531(Genuity Bloogard^TM) for example. The results showed that in the field of the transgenic cotton MON531, there are three valid patents in multiple countries, which made an effective and overall protection of the main functional gene, regulatory elements and the commercial varieties. And for the plant variety rights, nineteen plant varieties have been authorized in America, while only one related application has been examined in China. The strategy research of intellectual property protection related the cotton event MON531 can be used for reference for making our development of genetically modified crops and intellectual property protection.

Key words： Transnational Corporation Transgenic MON531 Intellectual Property Protection Strategy

Received: 29 September 2013 Published: 25 June 2014

ZTFLH:

Q819

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

SONG Min, LIU Na, REN Xin-xin, LU Yao. Analysis of Intellectual Property Protection Strategy of Transnational Biotechnology Corporation——Taking MON531 of Cotton Event for Example. China Biotechnology, 2014, 34(06): 110-116.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140616 OR https://manu60.magtech.com.cn/biotech/Y2014/V34/I06/110

[1] Vaeck M, Reynaerts A. Transgenic plants protected from insect attack. Nature,1987, 328 (2):33-37.

[2] Clive James.2012年全球生物技术/转基因作物商业化发展态势.中国生物工程杂志,2013, 33 (2):1-8. Clive James. Global status of commercialized biotech／GM crops,2012.China Biotechnology, 2013, 33 (2):1-8.

[3] Clive James. 2011年全球生物技术/转基因作物商业化发展态势.中国生物工程杂志,2012, 32 (1):1-14. Clive James. Global status of commercialized biotech／GM crops,2011. China Biotechnology, 2012, 32 (1):1-14.

[4] 刘定富,刘立清. 全球转基因棉花商业化进程.中国种业,2012,12: 11-13. Liu D F, Liu LQ. Commercialization progress of Transgenic Cotton in the global. China Seed Industry, 2012,12: 11-13.

[5] 陈健鹏.跨国种业公司成长的启示.农村工作通讯, 2012,4: 26-27. Chen S P. Enlightenment of the development of the multinational seed companies. Newsletter about Work in Rural Areas, 2012,4: 26-27.

[6] Peferon M. Progress and protects for field use of Bt. genes in crops. Trends in Biotechnology, 1997,15 (5):173-177.

[7] David A Fischhoff, Webster Groves, Frederick J Perlak, et al. Synthetic plant genes and method for preparation. US, US7741118, 2010-06-22.

[8] Joan C McPherson, Robert Kay. Method for enhanced expression of a DNA sequence of interest.US, US5424200,1995-06-13.

[9] Kim A Beazley, Kirk W, Jeanna R Hillyard, et al.Cotton event PV-GHBK04 (531) and compositions and methods for detection thereof.US,US7964348,2011-06-21.

[10] Fraley Robert T, Horsch Robert B, Rogers Stephen G.Chimeric genes for transforming plant cells using viral promoters.US, US5352605, 1994-10-04.

[11] Paul F Umbeck. Genetic engineering of cotton plants and lines.US,US5004863,1991-04-02.

[12] Scott A Huber, Creve Coeur, James K Roberts, et al.Cotton event MON15985 and compositions and methods for detection thereof.US, US7223907, 2011-06-21.

[13] S.A.胡伯, J.K.罗伯茨, Z.W.沙普利,等.棉花事件MON15985以及检测它的组合物和方法.中国, ZL 02802047.2. 2009-01-07. Scott A Huber, Creve Coeur, James K Roberts, et al.Cotton event MON15985 and compositions and methods for detection thereof.CN, ZL 02802047.2, 2009-01-07.

[14] 张欣欣. 跨国公司知识产权战略探析.税务与经济,2009,1:54-59. Zhang X X. Analysis of intellectual property rights strategy of transnational corporations. Taxation and Economy, 2009,1:54-59.

[15] 任静,刘丽军,宋敏.跨国公司在我国农业领域的技术锁定策略与对策研究.中国软科学,2012,1:39-46. Ren J, Liu L J, Song M. Technology locking strategy of transnational corporation in China's agriculture and China's countermeasures. China Soft Science Magazine, 2012,1:39-46.

[1]	HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.

[2]	LIANG Zhen-xin,LIU Fang,ZHANG wei,LIU Qing-you,LI Li. The Preparation and Validation of p185 ^erb ^B2 Human-mouse Chimeric Antibody ChAb26 Transgenic Mice Mammary Gl and Bioreactor[J]. China Biotechnology, 2019, 39(8): 40-51.

[3]	WANG You-hua,ZOU Wan-nong,LIU Xiao-qing,WANG Zhaohua,SUN Guo-qing. Global Patent Analysis and Technology Prospect of Genetically Modified Maize[J]. China Biotechnology, 2019, 39(12): 83-94.

[4]	YANG Fei-yun,YANG Tian-rui,LIU Kun,CUI Shuang,WANG Rui-gang,LI Guo-jing. *Flavonoids Metabolism and Antimicrobial Activity of Arabidopsis* Heterologous Expressing CiRS Gene**[J]. China Biotechnology, 2019, 39(11): 22-30.

[5]	CHEN Xiu-xiu,WU Cheng-lin,ZHOU Li-jun. Research Progress in Preparation and Clinical Application of Therapeutic Human Antibodies[J]. China Biotechnology, 2019, 39(10): 90-96.

[6]	Ming-ming HAN,Yu-ping LUO. Establishment and Identification of Endogenous CD133 ⁺ Cell Tracer Mouse Model[J]. China Biotechnology, 2018, 38(6): 58-62.

[7]	Min YAO,Shu-hua ZHU,Fo-sheng LI,Shi-yan ZHANG,Lin TANG. *Analysis of Salt Tolerance and Insect Resistance of Transgenic Tobacco Expressing AtCYSa* from Arabidopsis**[J]. China Biotechnology, 2018, 38(4): 8-16.

[8]	Fei-yun YANG,Yan-yan WU,Shuang CUI,Xiu-juan ZHANG,Rui-gang WANG,Guo-jing LI. *Heterologous Expression of CiRS* Gene Eenhances the Antioxidant Capacity of Arabidopsis by Increasing the Content of Resveratrol**[J]. China Biotechnology, 2017, 37(12): 27-33.

[9]	GE Lin, LIU Xin-yu, WANG Guirong. Construction of Human SP-B Protein Transgenic Mice and Bacterial Pneumonia Model[J]. China Biotechnology, 2017, 37(10): 65-71.

[10]	ZUO Zhi-yu, XIN Ling-biao, YANG Jie, WANG Xin-ting. *Construction of SND1* Transgenic Mice**[J]. China Biotechnology, 2016, 36(4): 97-103.

[11]	WANG Xu-jing, ZHANG Xin, LIU Pei-lei, WANG Zhi-xing. The Application and Safety Assessment of Stacked Transgenic Plant[J]. China Biotechnology, 2016, 36(4): 18-23.

[12]	MA Cai-yun, PANG Jin-hui, SHI Xiao-hua, HU Rui-fa. Malatesta's Transgenic Research: Citation Analysis and Relevant Evidence[J]. China Biotechnology, 2016, 36(4): 12-17.

[13]	LI Dong qiao, GUO Wen jiao, CHEN Fang. Research on Development Trend of Transgenic Medicinal Plant Technology Based on Patent Analysis[J]. China Biotechnology, 2016, 36(11): 98-108.

[14]	YU Xiu-min, YUE Wen-ran, ZHANG Yan-na, YANG Fei-yun, WANG Rui-gang, LI Guo-jing, YANG Qi. Heterologous of CkLEA1 Gene Enhanced Tolerance to Abiotic Stress in Arabidopsis[J]. China Biotechnology, 2016, 36(10): 28-34.

[15]	LI Hong-chang, YUAN Lin, ZHANG Ling-qiang . Construction of Transgenic Mice and Phenotypic Analysis of Tumor Suppressor PTEN[J]. China Biotechnology, 2015, 35(8): 1-8.

Viewed

Full text

Abstract

Cited

Shared

Discussed